Literature DB >> 12192274

Hepatitis viruses and hepatocellular carcinoma in HIV-infected patients.

Avram J Smukler1, Lee Ratner.   

Abstract

Hepatocellular carcinoma, the most common primary cancer of the liver, results in significant morbidity and mortality. Several disease entities have been shown to predispose to hepatocellular carcinoma. In most cases, however, hepatitis B virus, hepatitis C virus, and cirrhosis are the principal etiologic factors. In HIV-positive patients, a significant increase in the incidence of certain malignancies has been noted. Although HIV and the hepatitis viruses share common modes of transmission, an increase in the incidence of hepatocellular carcinoma in the patients with HIV has not been observed. This finding may be a function of premature death in patients with HIV before the advent of effective antiretroviral therapy. The introduction of such therapy may alter the epidemiology of hepatocellular carcinoma and strain health services, because current treatment options targeting both the underlying causative viruses and liver cancer itself are unsatisfactory and are the subject of ongoing research.

Entities:  

Mesh:

Year:  2002        PMID: 12192274     DOI: 10.1097/00001622-200209000-00011

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  7 in total

Review 1.  The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

Authors:  John F Deeken; Angelique Tjen-A-Looi; Michelle A Rudek; Catherine Okuliar; Mary Young; Richard F Little; Bruce J Dezube
Journal:  Clin Infect Dis       Date:  2012-07-09       Impact factor: 9.079

2.  Hepatocellular carcinoma in HIV-infected patients: check early, treat hard.

Authors:  Massimiliano Berretta; Elisa Garlassi; Bruno Cacopardo; Alessandro Cappellani; Giovanni Guaraldi; Stefania Cocchi; Paolo De Paoli; Arben Lleshi; Immacolata Izzi; Augusta Torresin; Pietro Di Gangi; Antonello Pietrangelo; Mariachiara Ferrari; Alessandra Bearz; Salvatore Berretta; Guglielmo Nasti; Fabrizio Di Benedetto; Luca Balestreri; Umberto Tirelli; Paolo Ventura
Journal:  Oncologist       Date:  2011-08-25

3.  Prevalence of Hepatocellular Carcinoma in HIV Patients Co-infected or Triple Infected With Hepatitis B and Hepatitis C in a Community Hospital in South Bronx.

Authors:  Shehriyar Mehershanhi; Asim Haider; Sameer Kandhi; Haozhe Sun; Harish Patel
Journal:  Cureus       Date:  2022-06-19

Review 4.  Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era.

Authors:  Douglas C MacDonald; Mark Nelson; Mark Bower; Thomas Powles
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

5.  Cumulative HIV viremia and non-AIDS-defining malignancies among a sample of HIV-infected male veterans.

Authors:  Marc A Kowalkowski; Rena S Day; Xianglin L Du; Wenyaw Chan; Elizabeth Y Chiao
Journal:  J Acquir Immune Defic Syndr       Date:  2014-10-01       Impact factor: 3.731

6.  Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.

Authors:  Patrícia Dos Santos Marcon; Cristiane Valle Tovo; Dimas Alexandre Kliemann; Patrícia Fisch; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2018-02-07       Impact factor: 5.742

7.  Risk of cancer in persons with AIDS in Italy, 1985-1998.

Authors:  L Dal Maso; S Franceschi; J Polesel; C Braga; P Piselli; E Crocetti; F Falcini; S Guzzinati; R Zanetti; M Vercelli; G Rezza
Journal:  Br J Cancer       Date:  2003-07-07       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.